• Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied?

    Source: NASDAQ International / 28 Jun 2016 01:14:49   America/New_York

    Image source Getty Images. When it comes to serious adverse events in clinical trials, one could be a fluke. But as Regulus Therapeutics (NASDAQ RGLS) discovered, if the same side effect happens http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/1qO69Uenly0/regulus-therapeutics-inc-clinical-hold-should-investors-be-yellow-bellied-cm641817
Share on,